224 related articles for article (PubMed ID: 35593958)
1. Ultrasound-guided microwave and radiofrequency ablation for primary hyperparathyroidism: a prospective, multicenter study.
Liu F; Liu Y; Peng C; Yu M; Wu S; Qian L; Han Z; Yu J; Chai H; Liang P
Eur Radiol; 2022 Nov; 32(11):7743-7754. PubMed ID: 35593958
[TBL] [Abstract][Full Text] [Related]
2. Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism.
Ni W; Yuan Y; Chu X; Chen G; Han X; Li J; Wu X; Wang J; Liu C; Xu S
Front Endocrinol (Lausanne); 2021; 12():782050. PubMed ID: 34925241
[TBL] [Abstract][Full Text] [Related]
3. Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study.
Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Chai HH; Yu MA
Int J Hyperthermia; 2021; 38(1):1023-1030. PubMed ID: 34219596
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study.
Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Yu MA
J Clin Endocrinol Metab; 2021 Aug; 106(9):2707-2717. PubMed ID: 33846740
[TBL] [Abstract][Full Text] [Related]
5. Risk factors influencing cure of ultrasound-guided microwave ablation for primary hyperparathyroidism.
Liu F; Zang L; Liu Y; Yu X; Cheng Z; Han Z; Yu J; Liang P
Int J Hyperthermia; 2022; 39(1):258-264. PubMed ID: 35109732
[TBL] [Abstract][Full Text] [Related]
6. Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis.
Xu W; Li S; Cheng F; Gong L; Tang W; Lu J; Li Y; Wang Z
Int Urol Nephrol; 2023 Sep; 55(9):2237-2247. PubMed ID: 36892812
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Primary Hyperparathyroidism: A Prospective Study.
Chai HH; Zhao Y; Zeng Z; Ye RZ; Hu QH; He HF; Baek JH; Peng CZ
Korean J Radiol; 2022 May; 23(5):555-565. PubMed ID: 35506529
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of efficacy of ultrasound-guided microwave ablation in primary hyperparathyroidism.
Zhang M; Gao Y; Zhang X; Ding Z; Wang X; Jiang W; Zhao C
J Clin Ultrasound; 2022 Feb; 50(2):227-235. PubMed ID: 34984687
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and safety of ultrasound-guided microwave ablation for the treatment of primary hyperparathyroidism in 12 patients with parathyroid adenoma].
Ni WJ; Chu XQ; Lu CY; Chen GF; Han X; Xu Y; Wu XP; Wang JH; Liu C; Xu SH
Zhonghua Nei Ke Za Zhi; 2021 Oct; 60(10):904-907. PubMed ID: 34551480
[TBL] [Abstract][Full Text] [Related]
10. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study.
Fan BQ; He XW; Chen HH; Zhang WM; Tang W
Eur Radiol; 2019 Oct; 29(10):5607-5616. PubMed ID: 30888479
[TBL] [Abstract][Full Text] [Related]
11. Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.
Wei Y; Peng L; Li Y; Zhao ZL; Yu MA
Korean J Radiol; 2020 May; 21(5):572-581. PubMed ID: 32323502
[TBL] [Abstract][Full Text] [Related]
12. Role of Sonazoid-based contrast-enhanced ultrasonography in the microwave ablation of primary hyperparathyroidism.
Zhou ZB; Xue YE; Yao YW; Zhang XT; Zhang MH; Yang DX; Xie JH
Int J Hyperthermia; 2022; 39(1):155-161. PubMed ID: 35000496
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism.
Liu F; Yu X; Liu Z; Qiao Z; Dou J; Cheng Z; Han Z; Yu J; Liang P
Int J Hyperthermia; 2019; 36(1):835-840. PubMed ID: 31452422
[No Abstract] [Full Text] [Related]
14. Two-year changes of biochemical profiles and bone mineral density after percutaneous ultrasound-guided microwave ablation for primary hyperparathyroidism.
Wu W; Zhou Q; Xu S; An S; Shen F; Li H; Gong X; Chen X
Endocrine; 2021 Feb; 71(2):476-483. PubMed ID: 33025562
[TBL] [Abstract][Full Text] [Related]
15. Comparison between ultrasound-guided percutaneous radiofrequency and microwave ablation in benign thyroid nodules.
Hu K; Wu J; Dong Y; Yan Z; Lu Z; Liu L
J Cancer Res Ther; 2019; 15(7):1535-1540. PubMed ID: 31939434
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided ablative therapy for hepatic malignancies : a comparison of the therapeutic effects of microwave and radiofrequency ablation.
Zhang XG; Zhang ZL; Hu SY; Wang YL
Acta Chir Belg; 2014; 114(1):40-5. PubMed ID: 24720137
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-Guided Radiofrequency Ablation for the Treatment of Primary Hyperparathyroidism: An Efficacy and Safety Study.
Li X; Tufano RP; Russell JO; Yan L; Xiao J; Li Y; Zhang M; Luo Y
Endocr Pract; 2021 Dec; 27(12):1205-1211. PubMed ID: 34311118
[TBL] [Abstract][Full Text] [Related]
18. Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics.
Ha EJ; Baek JH; Baek SM
Korean J Radiol; 2020 Dec; 21(12):1383-1392. PubMed ID: 32767864
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
[TBL] [Abstract][Full Text] [Related]
20. Microwave ablation versus parathyroidectomy for the treatment of primary hyperparathyroidism: a cohort study.
Wei Y; Zhao ZL; Cao XJ; Peng LL; Li Y; Wu J; Yu MA
Eur Radiol; 2022 Sep; 32(9):5821-5830. PubMed ID: 35381852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
